Inventiva S.A. (IVA.PA)
EUR 2.15
(2.38%)
EUR 2.15
(2.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 10.48 Million EUR | 120.09% |
| 2022 | -52.22 Million EUR | 31.68% |
| 2021 | -76.43 Million EUR | 17.31% |
| 2020 | -92.43 Million EUR | -173.96% |
| 2019 | -33.73 Million EUR | 38.08% |
| 2018 | -54.48 Million EUR | 6.97% |
| 2017 | -58.56 Million EUR | -141.62% |
| 2016 | -24.23 Million EUR | -10.7% |
| 2015 | -21.89 Million EUR | -28.56% |
| 2014 | -17.03 Million EUR | -27.48% |
| 2013 | -13.36 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 10.48 Million EUR | 0.0% |
| 2023 FY | 10.48 Million EUR | 120.09% |
| 2023 Q2 | 3.89 Million EUR | 0.0% |
| 2022 FY | -52.22 Million EUR | 31.68% |
| 2022 Q2 | -57.87 Million EUR | 0.0% |
| 2022 Q4 | -52.22 Million EUR | 0.0% |
| 2021 FY | -76.43 Million EUR | 17.31% |
| 2021 Q1 | -94.52 Million EUR | -2.26% |
| 2021 Q2 | -83.54 Million EUR | 11.62% |
| 2021 Q4 | -76.43 Million EUR | 0.0% |
| 2020 FY | -92.43 Million EUR | -173.96% |
| 2020 Q2 | -40.26 Million EUR | 0.0% |
| 2020 Q4 | -92.43 Million EUR | 0.0% |
| 2019 Q4 | -33.73 Million EUR | 0.0% |
| 2019 FY | -33.73 Million EUR | 38.08% |
| 2019 Q2 | -34.82 Million EUR | 0.0% |
| 2018 Q4 | -54.48 Million EUR | 0.0% |
| 2018 FY | -54.48 Million EUR | 6.97% |
| 2018 Q2 | -75.67 Million EUR | 0.0% |
| 2017 FY | -58.56 Million EUR | -141.62% |
| 2017 Q4 | -58.56 Million EUR | 0.0% |
| 2017 Q2 | -63.86 Million EUR | 0.0% |
| 2016 Q4 | -24.23 Million EUR | 0.0% |
| 2016 FY | -24.23 Million EUR | -10.7% |
| 2016 Q2 | -22.17 Million EUR | 0.0% |
| 2015 FY | -21.89 Million EUR | -28.56% |
| 2015 Q4 | -21.89 Million EUR | 0.0% |
| 2014 FY | -17.03 Million EUR | -27.48% |
| 2013 FY | -13.36 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ABIONYX Pharma SA | -714 Thousand EUR | 1569.048% |
| ABIVAX Société Anonyme | -196.47 Million EUR | 105.339% |
| Adocia SA | 127 Thousand EUR | -8159.055% |
| Aelis Farma SA | -16.19 Million EUR | 164.779% |
| Biophytis S.A. | 2.7 Million EUR | -288.05% |
| Advicenne S.A. | 12.17 Million EUR | 13.848% |
| genOway Société anonyme | 2.97 Million EUR | -252.812% |
| IntegraGen SA | -709.74 Thousand EUR | 1577.846% |
| Medesis Pharma S.A. | 1.15 Million EUR | -805.622% |
| Neovacs S.A. | -237.08 Thousand EUR | 4524.114% |
| NFL Biosciences SA | -2.27 Million EUR | 560.879% |
| Plant Advanced Technologies SA | 4.35 Million EUR | -140.766% |
| Quantum Genomics Société Anonyme | -830.54 Thousand EUR | 1362.901% |
| Sensorion SA | 1.37 Million EUR | -661.053% |
| Theranexus Société Anonyme | 2.44 Million EUR | -329.146% |
| TME Pharma N.V. | -1.07 Million EUR | 1072.104% |
| Valbiotis SA | -18.13 Million EUR | 157.826% |
| TheraVet SA | 12.78 Thousand EUR | -81941.455% |
| Valerio Therapeutics Société anonyme | 2.18 Million EUR | -381.147% |
| argenx SE | -1.83 Billion EUR | 100.571% |
| BioSenic S.A. | 28.04 Million EUR | 62.598% |
| Celyad Oncology SA | -6.1 Million EUR | 271.894% |
| DBV Technologies S.A. | -114.95 Million USD | 109.124% |
| Galapagos NV | -157.2 Million EUR | 106.672% |
| Genfit S.A. | -7.61 Million EUR | 237.814% |
| GeNeuro SA | 5.91 Million EUR | -77.467% |
| Hyloris Pharmaceuticals SA | -25.11 Million EUR | 141.769% |
| Innate Pharma S.A. | -30.71 Million EUR | 134.153% |
| MaaT Pharma SA | -10.2 Million EUR | 202.783% |
| MedinCell S.A. | 39.5 Million EUR | 73.446% |
| Nanobiotix S.A. | -24.71 Million EUR | 142.435% |
| Onward Medical N.V. | -12.89 Million EUR | 181.348% |
| Oryzon Genomics S.A. | 1.43 Million EUR | -633.325% |
| OSE Immunotherapeutics SA | 27.12 Million EUR | 61.337% |
| Oxurion NV | 10.71 Million EUR | 2.063% |
| Pharming Group N.V. | 99.4 Million EUR | 89.448% |
| Poxel S.A. | 44.55 Million EUR | 76.46% |
| GenSight Biologics S.A. | 16.29 Million EUR | 35.627% |
| Transgene SA | -14.4 Million EUR | 172.795% |
| Financière de Tubize SA | 78.62 Million EUR | 86.659% |
| UCB SA | 2.17 Billion EUR | 99.518% |
| Valneva SE | 82.73 Million EUR | 87.322% |
| Vivoryon Therapeutics N.V. | -18.52 Million EUR | 156.624% |